Understanding Change Data in LesionQuant 2.3

Did you know that the LesionQuant module offers lesion and brain structure change data for review?

Lesion and brain structure change data is available when a current and prior LesionQuant study have been processed and are available in the queue monitor. Change values of lesions are determined by using both 3D T1 and (2D or 3D) T2 FLAIR MRIs.

Morphometry Results
The change calculation of brain structures provides the difference between the current and prior scan brain volumes, percent of ICV, and normative percentile.

Cortechs.ai | Understanding Change Data in LesionQuant 2.3

Data from the prior study will also be included in the report for both lesions and brain volumes. Additionally, multi time-point-plotting displays the current and prior measurements on the same same report, allowing for ongoing patient evaluation with longitudinal tracking.

Lesion Results

  • Compare lesion count, volume and %ICV to prior scan
  • Review new and enlarging lesions, and the sum of the new and enlarging lesions
  • Evaluate where new and enlarging lesions are anatomically located, and examine the count of new lesions and the volume of new, enlarging and the sum of the new and enlarging lesions

Cortechs.ai | Understanding Change Data in LesionQuant 2.3

Cortechs.ai | Understanding Change Data in LesionQuant 2.3

 

Lesion Size Distribution Histogram
The histogram of lesion size distribution displays number of lesions within each lesion size bracket for current and prior scans. This data can characterize global lesion changes and provide an indication of disease progression.

Reproducibility and Comparison Best Practices
It is best practice to perform the current MRI on the same MRI scanner and series protocol as the prior MRI. If different scanners and/or protocols are used, caution should be taken when interpreting the results.

When patient data is already in the system
If an earlier scan for the patient has been processed by LesionQuant (same software version) and is available in the queue monitor, change volume images are automatically included in the output sent to the PACS/DICOM Viewer. The PatientID must match on both time points, and the StudyInstanceUID must match on the individual T1/FLAIR pair.

When patient data is no longer in the system or there has been a change in the software version from the prior scan
To obtain the change visualization, the user must reprocess the prior scan pair, then send the current scan pair for processing to receive the change analysis and volumes. The PatientID must match on both time points, and the StudyInstanceUID must match on the individual T1/FLAIR pair.

If the prior study is sent to LesionQuant for comparison reprocessing, it is important that the prior T1/FLAIR pair is processed completely before submitting the current T1/FLAIR pair.

More Resources

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists

02/15/2025

NeuroQuant® Dementia: Advancing Alzheimer’s Disease Care in the Era of DMTs

AI-driven brain volumetric analysis is revolutionizing Alzheimer’s care, providing precise diagnostic support, monitoring, and early detection.

02/09/2025

NeuroQuant® MS:  Advancing Precision in Multiple Sclerosis

Dr. Suzie Bash discusses NeuroQuant MS, noting its ability to segment plaques, analyze volume, and track lesion burden for assessing disease progression
Scroll to Top